Clinical Trial Update: Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vaginal dinoprostone administration prior to T380A intrauterine device insertion in nulliparous women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Device

Drugs mentioned

• Dinoprostone (dinoprostone)
• T380A intrauterine device (intrauterine device (T380A))

Snippet

Sponsor: Cairo University | Conditions: Intrauterine Device | Phase 3 | Status: COMPLETED